Literature DB >> 6259378

Complications of retroperitoneal lymph node dissection.

J P Donohue, R G Rowland.   

Abstract

We reviewed the surgical morbidity in 235 patients who underwent retroperitoneal dissection for testis cancer. Of these patients 95 had stage I, 91 had stage II and 49 had stage III disease, and underwent a secondary or primary cytoreductive operation. In the early postoperative period there were 19 major complications in 13 patients (5.5 per cent) and 19 minor complications in 15 patients (6 per cent). There also were 3 late postoperative complications, 2 of which required re-hospitalization. Therefore, the over-all rate of 38 early major and minor complications in 28 patients (11.9 per cent) compares favorably to other reports. These complications generally are treated easily an successfully. However, there is a striking increase in the incidence of operative difficulties and postoperative complications in patients with advanced disease (stage III). Of 49 such patients there were 13 complications. One patient had multiple complications. Also, all patients who had an extensive primary cytoreductive operation suffered either intraoperative or postoperative complications. It is concluded that the complication rate is related directly to the extent of the disease. Factors contributing to this rate are increased operative time, added technical demands, diminished reserve and nutritional status of these patients, and the effects of prior chemotherapy. Therefore, a new population is emerging in cases of testis cancer, namely patients with extensive disease who have had prolonged intensive chemotherapy that alters the pulmonary, hematologic an nutritional status. Specific difficulties are noted and suggestions for management are reviewed.

Entities:  

Mesh:

Year:  1981        PMID: 6259378     DOI: 10.1016/s0022-5347(17)55029-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.

Authors:  J G Hay; P L Haslam; A Dewar; B Addis; M Turner-Warwick; G J Laurent
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

Review 2.  Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.

Authors:  C Bokemeyer; M A Kuczyk; J Serth; J T Hartmann; H J Schmoll; U Jonas; L Kanz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.

Authors:  D S Klein; P R Wilds
Journal:  Can Anaesth Soc J       Date:  1983-07

4.  A case of left renal atrophy following the development of an infected giant retroperitoneal chylous cyst after laparoscopic para-aortic lymphadenectomy for endometrial cancer.

Authors:  Takuma Ohsuga; Yasushi Kotani; Shiro Takamatsu; Keisuke Murakami; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Int Cancer Conf J       Date:  2020-06-09

5.  Prognosis of testicular tumour since the introduction of complex therapy.

Authors:  D Frang; L Farkas; F Götz; J Székely
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

6.  Sexual functioning among testicular cancer survivors: a case-control study in the U.S.

Authors:  Christopher Kim; Katherine A McGlynn; Ruth McCorkle; Yonghong Li; Ralph L Erickson; Shuangge Ma; David W Niebuhr; Guangsheng Zhang; Yaqun Zhang; Yana Bai; Li Dai; Barry I Graubard; Tongzhang Zheng; Briseis Aschebrook-Kilfoy; Kathryn H Barry; Yawei Zhang
Journal:  J Psychosom Res       Date:  2012-04-21       Impact factor: 3.006

Review 7.  Long-term complications of chemotherapy for germ cell tumours.

Authors:  Uzair B Chaudhary; Jason R Haldas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer.

Authors:  J Baniel; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Renal function related to different treatment modalities for malignant germ cell tumours.

Authors:  N Aass; S D Fosså; M Aas; M W Lindegaard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

10.  The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.

Authors:  G Read; R J Johnson; P M Wilkinson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.